What level of unit is Optics Valley Biological City?

Optical Valley Biological City is a national industrial base. Optics Valley Bio-city (Wuhan National Bio-industrial Base) is located in the East Lake National Independent Innovation Demonstration Zone in Wuhan, and it is the second national industrial base built by China Optics Valley with the idea of "100 billion industries".

Optical Valley Bio-City started construction in June 2008 +065438+ 10, focusing on biomedicine, biomedical engineering, bio-agriculture, accurate diagnosis and treatment, smart medical care, biological services and other fields.

Bio-innovation Park, Biomedical Park, Bio-agriculture Park, Medical Device Park, Medical Health Park and Smart Health Park have been built, and the construction of Life Health Park is being vigorously promoted to create a new bio-industry city integrating R&D, incubation, production, logistics and life.

Park goal

By 2020, Optics Valley Bio-City will realize the total income of bio-industry exceeding 300 billion yuan, and become a "national leading, first-class in Asia and internationally renowned" bio-health industry center, which will drive the total income of bio-health industry in Hubei Province to exceed 800 billion yuan and become one of the "Troika" of strategic emerging industries in Hubei Province.

1. Industrial scale target: By 20 18, the total income of bio-health industry in Donghu High-tech Zone will exceed 200 billion yuan; By 2020, the total income of bio-health industry in Donghu High-tech Zone will exceed 300 billion yuan.

2. Enterprise cultivation goal: By 2020, 2,000 bio-health enterprises will be gathered, and 2 leading enterprises with annual income exceeding 50 billion yuan will be cultivated, and more than one leading enterprise with annual income exceeding 10.

3. Innovation capacity improvement goal: a number of key core technologies and innovation carriers have reached the international advanced level, and 8- 10 innovation alliances have been added in the field of biology and health. R&D investment of major leading enterprises accounts for more than 5% of sales revenue, and the total number of national and provincial technology R&D centers and R&D institutions reaches 100. The number of patent achievements in innovative drugs and biotechnology in advantageous areas has increased significantly.

4. Service system construction goal: make every effort to build a number of high-level technical service platforms oriented to industry and market operation, add 20 collaborative innovation platforms, and introduce 50 professional service institutions specializing in technology trading, investment and operation, exhibition and exchange, policy consultation, enterprise incubation service, CFDA registration and international certification services.

5. Talent team construction goal: introduce and train a group of high-level biotechnology talents and teams with all efforts, in which the total number of "Hundred Talents Program" reaches 150 and the total number of "355 1" reaches 800.